Unum Therapeutics Inc.

Unum Therapeutics Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Unum Therapeutics Inc. is not a good value stock. Unum Therapeutics Inc. is not very popular among insiders. Unum Therapeutics Inc. is a mediocre stock to choose.
Log in to see more information.
Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and...

News